Consultation: inclisiran information for primary care prescribers

A new consultation has been opened on the GMMMG consultations page on a draft information leaflet for inclisiran. 

The draft provides additional advice and information for prescribers, and is intended to support primary care prescribers and ensure a quality standard for the prescribing of inclisiran.

The consultation will be open until 5pm on Tuesday 3rd May 2022, and comments are invited from all stakeholders.

New consultations: high cost drugs pathways

Two new consultations have been opened on the GMMMG consultations page. The topics are:

  • High cost drugs pathway: psoriatic arthritis
  • High cost drugs pathway: axial spondyloarthritis

These consultations will be open until 5pm on Thursday 22nd March 2022, and comments are invited from all stakeholders.

GMMMG are mindful of additional service pressures at present therefore if you foresee any problems giving input on these consultations, or if you have any questions, please contact the secretariat at nuth.enquires.gmmmg@nhs.net.